This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Janssen Pharmaceutica Nv. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations by Inventor Rene Holm
Introduction
Rene Holm is an accomplished inventor based in Woluwe Saint Pierre, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that include ibrutinib. His work has the potential to impact the treatment of various diseases and conditions.
Latest Patents
Rene Holm holds 1 patent for his innovative work. His patent, titled "Formulations/compositions comprising ibrutinib," discloses formulations and compositions that incorporate ibrutinib. The patent also details processes for preparing these formulations and methods of treatment that utilize them.
Career Highlights
Rene Holm is associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His role at the company has allowed him to focus on developing advanced therapeutic solutions that can improve patient outcomes.
Collaborations
Rene has collaborated with notable coworkers, including Maristella Bernini and Wenyu Dong. These partnerships have fostered a collaborative environment that enhances innovation and research in the pharmaceutical sector.
Conclusion
Rene Holm's contributions to the field of pharmaceuticals, particularly through his patent on ibrutinib formulations, highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile